p.92 抽出テキスト
716. Joffre J, Dumas G, Aegerter P, Dubee V, Bige N, Preda G, et al. Epidemiology of infective endocarditis in French intensive care units over the 1997–2014 period-from CUB-rea network. Crit Care 2019;23:143. https://doi.org/10.1186/s13054-019-2387-8 717. Georges H, Leroy O, Airapetian N, Lamblin N, Zogheib E, Devos P, et al. Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission. BMC Infect Dis 2018;18:85. https://doi.org/10.1186/s12879-018- 2989-9 718. Leroy O, Georges H, Devos P, Bitton S, De Sa N, Dedrie C, et al. Infective endocarditis requiring ICU admission: epidemiology and prognosis. Ann Intensive Care 2015;5:45. https://doi.org/10.1186/s13613-015-0091-7 719. Samol A, Kaese S, Bloch J, Gorlich D, Peters G, Waltenberger J, et al. Infective endocarditis on ICU: risk factors, outcome and long-term follow-up. Infection 2015;43: 287–295. https://doi.org/10.1007/s15010-014-0715-0 720. Arntfield R, Lau V, Landry Y, Priestap F, Ball I. Impact of critical care transesophageal echocardiography in medical-surgical ICU patients: characteristics and results from 274 consecutive examinations. J Intensive Care Med 2020;35:896–902. https://doi. org/10.1177/0885066618797271 721. Belletti A, Jacobs S, Affronti G, Mladenow A, Landoni G, Falk V, et al. Incidence and predictors of postoperative need for high-dose inotropic support in patients undergoing cardiac surgery for infective endocarditis. J Cardiothorac Vasc Anesth 2018;32: 2528–2536. https://doi.org/10.1053/j.jvca.2017.12.015 722. van den Brink FS, van Tooren R, Sonker U, Klein P, Waanders F, Zivelonghi C, et al. Veno arterial-extra corporal membrane oxygenation for the treatment of cardiac failure in patients with infective endocarditis. Perfusion 2019;34:613–617. https://doi.org/ 10.1177/0267659119842807 723. Lassen H, Nielsen SL, Gill SUA, Johansen IS. The epidemiology of infective endocarditis with focus on non-device related right-sided infective endocarditis: a retrospective register-based study in the region of southern Denmark. Int J Infect Dis 2020;95: 224–230. https://doi.org/10.1016/j.ijid.2020.04.011 724. Sridhar AR, Lavu M, Yarlagadda V, Reddy M, Gunda S, Afzal R, et al. Cardiac implantable electronic device-related infection and extraction trends in the U.S. Pacing Clin Electrophysiol 2017;40:286–293. https://doi.org/10.1111/pace.13009 725. Witten JC, Hussain ST, Shrestha NK, Gordon SM, Houghtaling PL, Bakaeen FG, et al. Surgical treatment of right-sided infective endocarditis. J Thorac Cardiovasc Surg 2019; 157:1418–1427.e14. https://doi.org/10.1016/j.jtcvs.2018.07.112 726. Pfannmueller B, Kahmann M, Davierwala P, Misfeld M, Bakhtiary F, Binner C, et al. Tricuspid valve surgery in patients with isolated tricuspid valve endocarditis: analysis of perioperative parameters and long-term outcomes. Thorac Cardiovasc Surg 2017; 65:626–633. https://doi.org/10.1055/s-0035-1564926 727. Isaza N, Shrestha NK, Gordon S, Pettersson GB, Unai S, Vega Brizneda M, et al. Contemporary outcomes of pulmonary valve endocarditis: a 16-year single centre experience. Heart Lung Circ 2020;29:1799–1807. https://doi.org/10.1016/j.hlc.2020.04. 015 728. Hussain ST, Shrestha NK, Witten J, Gordon SM, Houghtaling PL, Tingleff J, et al. Rarity of invasiveness in right-sided infective endocarditis. J Thorac Cardiovasc Surg 2018;155: 54–61.e1. https://doi.org/10.1016/j.jtcvs.2017.07.068 729. San Roman JA, Vilacosta I, Lopez J, Revilla A, Arnold R, Sevilla T, et al. Role of transthoracic and transesophageal echocardiography in right-sided endocarditis: one echocardiographic modality does not fit all. J Am Soc Echocardiogr 2012;25:807–814. https:// doi.org/10.1016/j.echo.2012.05.016 730. Anton-Vazquez V, Cannata A, Amin-Youssef G, Watson S, Fife A, Mulholland N, et al. Diagnostic value of (18)F-FDG PET/CT in infective endocarditis. Clin Res Cardiol 2022; 111:673–679. https://doi.org/10.1007/s00392-021-01975-z 731. Weber C, Gassa A, Eghbalzadeh K, Merkle J, Djordjevic I, Maier J, et al. Characteristics and outcomes of patients with right-sided endocarditis undergoing cardiac surgery. Ann Cardiothorac Surg 2019;8:645–653. https://doi.org/10.21037/acs.2019.08.02 732. Shrestha NK, Jue J, Hussain ST, Jerry JM, Pettersson GB, Menon V, et al. Injection drug use and outcomes after surgical intervention for infective endocarditis. Ann Thorac Surg 2015;100:875–882. https://doi.org/10.1016/j.athoracsur.2015.03.019 733. Hussain ST, Witten J, Shrestha NK, Blackstone EH, Pettersson GB. Tricuspid valve endocarditis. Ann Cardiothorac Surg 2017;6:255–261. https://doi.org/10.21037/acs. 2017.03.09 734. Marks LR, Nolan NS, Liang SY, Durkin MJ, Weimer MB. Infectious complications of injection drug use. Med Clin North Am 2022;106:187–200. https://doi.org/10.1016/j. mcna.2021.08.006 735. Kelly MC, Yeager SD, Shorman MA, Wright LR, Veve MP. Incidence and predictors of Gram-negative bacilli in hospitalized people who inject drugs with injection drug use-attributable infections. Antimicrob Agents Chemother 2021;65:e0092521. https:// doi.org/10.1128/AAC.00925-21 736. Bisbe J, Miro JM, Latorre X, Moreno A, Mallolas J, Gatell JM, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 1992;15:910–923. https://doi.org/10.1093/clind/15.6.910 737. Meena DS, Kumar D, Agarwal M, Bohra GK, Choudhary R, Samantaray S, et al. Clinical features, diagnosis and treatment outcome of fungal endocarditis: a systematic review of reported cases. Mycoses 2022;65:294–302. https://doi.org/10.1111/myc.13398 738. Ribera E, Gomez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 1996;125:969–974. https://doi.org/10.7326/0003-4819-125-12- 199612150-00005 739. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet 2016;387:882–893. https:// doi.org/10.1016/S0140-6736(15)00067-7 740. Chong CZ, Cherian R, Ng P, Yeo TC, Ling LH, Soo WM, et al. Clinical outcomes of severe tricuspid valve infective endocarditis related to intravenous drug abuse – a case series. Acta Cardiol 2022;77:884–889. https://doi.org/10.1080/00015385.2021. 1976448 741. Syed IM, Yanagawa B, Jeyaganth S, Verma S, Cheema AN. Injection drug use endocarditis: an inner-city hospital experience. CJC Open 2021;3:896–903. https://doi.org/10. 1016/j.cjco.2021.02.015 742. Chahoud J, Sharif Yakan A, Saad H, Kanj SS. Right-sided infective endocarditis and pulmonary infiltrates: an update. Cardiol Rev 2016;24:230–237. https://doi.org/10.1097/ CRD.0000000000000095 743. Damlin A, Westling K. Patients with infective endocarditis and history of injection drug use in a Swedish referral hospital during 10 years. BMC Infect Dis 2021;21:236. https:// doi.org/10.1186/s12879-021-05914-1 744. Rose WE, Leonard SN, Sakoulas G, Kaatz GW, Zervos MJ, Sheth A, et al. Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2008;52:831–836. https://doi.org/10.1128/AAC.00869-07 745. Al-Omari A, Cameron DW, Lee C, Corrales-Medina VF. Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis 2014;14: 140. https://doi.org/10.1186/1471-2334-14-140 746. Marks LR, Liang SY, Muthulingam D, Schwarz ES, Liss DB, Munigala S, et al. Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections. Clin Infect Dis 2020;71:e650–e656. https://doi.org/10.1093/ cid/ciaa365 747. Slaughter MS, Badhwar V, Ising M, Ganzel BL, Sell-Dottin K, Jawitz OK, et al. Optimum surgical treatment for tricuspid valve infective endocarditis: an analysis of the Society of Thoracic Surgeons national database. J Thorac Cardiovasc Surg 2021;161:1227–- 1235.e1. https://doi.org/10.1016/j.jtcvs.2019.10.124 748. Misfeld M, Davierwala PM, Borger MA, Bakhtiary F. The “UFO” procedure. Ann Cardiothorac Surg 2019;8:691–698. https://doi.org/10.21037/acs.2019.11.05 749. Navia JL, Elgharably H, Hakim AH, Witten JC, Haupt MJ, Germano E, et al. Long-term outcomes of surgery for invasive valvular endocarditis involving the aortomitral fibrosa. Ann Thorac Surg 2019;108:1314–1323. https://doi.org/10.1016/j.athoracsur.2019.04. 119 750. Nappi F, Spadaccio C, Mihos C, Shaikhrezai K, Acar C, Moon MR. The quest for the optimal surgical management of tricuspid valve endocarditis in the current era: a narrative review. Ann Transl Med 2020;8:1628. https://doi.org/10.21037/atm-20-4685 751. Arbulu A, Holmes RJ, Asfaw I. Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience. J Heart Valve Dis 1993;2:129–137, discussion 138–139. 752. Brescia AA, Watt TMF, Williams AM, Romano MA, Bolling SF. Tricuspid valve leaflet repair and augmentation for infective endocarditis. Oper Tech Thorac Cardiovasc Surg 2019;24:206–218. https://doi.org/10.1053/j.optechstcvs.2019.09.002 753. Randhawa VK, Rajani R. Novel frontiers for managing tricuspid valve endocarditis: tales of percutaneous extracorporeal circuitry. JACC Case Rep 2021;3:1350–1353. https:// doi.org/10.1016/j.jaccas.2021.06.026 754. Starck CT, Dreizler T, Falk V. The AngioVac system as a bail-out option in infective valve endocarditis. Ann Cardiothorac Surg 2019;8:675–677. https://doi.org/10.21037/ acs.2019.11.04 755. Luc JGY, Choi J-H, Kodia K, Weber MP, Horan DP, Maynes EJ, et al. Valvectomy versus replacement for the surgical treatment of infective tricuspid valve endocarditis: a systematic review and meta-analysis. Ann Cardiothorac Surg 2019;8:610–620. https://doi. org/10.21037/acs.2019.11.06 756. Gabriel HM, Heger M, Innerhofer P, Zehetgruber M, Mundigler G, Wimmer M, et al. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol 2002;39:1066–1071. https://doi.org/10.1016/S0735-1097(02)01706-0 757. Moore B, Cao J, Kotchetkova I, Celermajer DS. Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. Int J Cardiol 2017;249:161–165. https://doi.org/10.1016/j.ijcard.2017.08.035 758. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021;42:563–645. https://doi.org/10.1093/eurheartj/ehaa554 759. Haas NA, Bach S, Vcasna R, Laser KT, Sandica E, Blanz U, et al. The risk of bacterial endocarditis after percutaneous and surgical biological pulmonary valve implantation. Int J Cardiol 2018;268:55–60. https://doi.org/10.1016/j.ijcard.2018.04.138 760. Hribernik I, Thomson J, Ho A, English K, Van Doorn C, Jaber O, et al. Comparative analysis of surgical and percutaneous pulmonary valve implants over a 20-year period. Eur J Cardiothorac Surg 2022;61:572–579. https://doi.org/10.1093/ejcts/ezab368 ESC Guidelines 4039 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026